| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.21 | 3e-08 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.19 | 4e-08 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.18 | 4e-08 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | -0.19 | 5e-08 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.18 | 5e-08 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.2 | 6e-08 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.21 | 6e-08 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.2 | 6e-08 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.19 | 6e-08 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | -0.2 | 7e-08 |